Scott Nash, MD

Director, Medical Affairs Immunology
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

Poster(s):

• (409) Dupilumab effectiveness through 24 months in patients from the United States with CRSwNP enrolled in the global AROMA registry
  Wednesday, October 29, 2025